Victory Capital Management Inc Esperion Therapeutics, Inc. Transaction History

Victory Capital Management Inc

  • $95.8 Billion
  • Q2 2024

A detailed history of Victory Capital Management Inc transactions in Esperion Therapeutics, Inc. stock. As of the latest transaction made, Victory Capital Management Inc holds 22,210 shares of ESPR stock, worth $36,424. This represents 0.0% of its overall portfolio holdings.

Number of Shares
22,210
Previous 24,179 8.14%
Holding current value
$36,424
Previous $64,000 23.44%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 05, 2024
SELL
$1.84 - $3.24 $3,622 - $6,379
-1,969 Reduced 8.14%
22,210 $49,000
Q1 2024

May 03, 2024
BUY
$2.02 - $3.02 $18,141 - $27,122
8,981 Added 59.09%
24,179 $64,000
Q4 2023

Feb 05, 2024
BUY
$0.73 - $3.08 $2,597 - $10,958
3,558 Added 30.57%
15,198 $45,000
Q3 2023

Nov 06, 2023
BUY
$0.96 - $1.79 $1,317 - $2,455
1,372 Added 13.36%
11,640 $11,000
Q2 2023

Jul 27, 2023
BUY
$1.2 - $1.76 $12,321 - $18,071
10,268 New
10,268 $14,000
Q3 2021

Nov 02, 2021
SELL
$11.34 - $21.37 $197,202 - $371,624
-17,390 Closed
0 $0
Q2 2021

Aug 03, 2021
SELL
$19.4 - $28.71 $13,366 - $19,781
-689 Reduced 3.81%
17,390 $368,000
Q1 2021

May 04, 2021
SELL
$25.12 - $36.89 $20,497 - $30,102
-816 Reduced 4.32%
18,079 $507,000
Q4 2020

Feb 01, 2021
SELL
$24.2 - $35.76 $22,481 - $33,221
-929 Reduced 4.69%
18,895 $491,000
Q3 2020

Nov 09, 2020
SELL
$31.18 - $52.71 $227,302 - $384,255
-7,290 Reduced 26.89%
19,824 $737,000
Q2 2020

Aug 07, 2020
BUY
$30.04 - $51.31 $409,325 - $699,150
13,626 Added 101.02%
27,114 $1.39 Million
Q1 2020

May 04, 2020
SELL
$27.44 - $73.84 $38,992 - $104,926
-1,421 Reduced 9.53%
13,488 $425,000
Q4 2019

Feb 06, 2020
BUY
$35.4 - $59.82 $46,515 - $78,603
1,314 Added 9.67%
14,909 $889,000
Q4 2019

Feb 04, 2020
SELL
$35.4 - $59.82 $21,487 - $36,310
-607 Reduced 4.27%
13,595 $735,000
Q3 2019

Nov 12, 2019
BUY
$34.47 - $47.53 $480,132 - $662,045
13,929 Added 5102.2%
14,202 $521,000
Q4 2018

Feb 05, 2019
SELL
$36.99 - $59.11 $1,923 - $3,073
-52 Reduced 16.0%
273 $13,000
Q3 2018

Nov 01, 2018
BUY
$40.74 - $51.41 $1,751 - $2,210
43 Added 15.25%
325 $14,000
Q2 2017

Aug 07, 2017
BUY
N/A
282
282 $13,000

Others Institutions Holding ESPR

# of Institutions
199
Shares Held
136M
Call Options Held
2.72M
Put Options Held
1.3M
View Full List

About Esperion Therapeutics, Inc.

ESPR Quotes by TradingView
  • Ticker ESPR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,551,600
  • Market Cap $109M
  • Description
  • Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...
More about ESPR
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email